Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | MAPK13 | O15264 | 5/20 | 0.54 |
| ▸ | MAPK12 | P53778 | 5/20 | 0.54 |
| ▸ | MAPK11 | Q15759 | 5/20 | 0.54 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.50 |
| ▸ | TUBB | P07437 | 3/20 | 0.50 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.50 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.50 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.50 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.50 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.50 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.50 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.50 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7042915 | 0.87 | ESR1 (0.79) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| SCHEMBL7038621 | 0.87 | ESR1 (0.79) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| SCHEMBL5193971 | 0.87 | ESR1 (0.73) | ESR1ESR2PTGS2MAPT | |
| SCHEMBL7039642 | 0.86 | ESR2 (0.77) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| SCHEMBL7042910 | 0.84 | PTGS2 (0.72) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| SCHEMBL7039067 | 0.84 | PTGS2 (0.72) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| Indoxole SCHEMBL42592 | 0.81 | PTGS2 (0.76) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| Indoxole SCHEMBL29519430 | 0.81 | PTGS2 (0.76) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| SCHEMBL7042896 | 0.81 | ESR1 (0.71) | ESR1ESR2PTGS2MAPK13MAPK12 | |
| SCHEMBL15057905 | 0.81 | PTGS2 (0.60) | ESR1ESR2PTGS2MAPK13MAPK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030220377-A1 | Indole compounds and their use as estrogen agonists/antagonists | CHESWORTH RICHARD (US) | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220377-A1 | Indole compounds and their use as estrogen agonists/antagonists | ESR1, GPER1, ESR2 | ESR1 1/4885ESR2 3/4885PTGS2 735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.